Last10K.com

Diamond Information Institute (TCEL) SEC Filing 8-K Material Event for the period ending Friday, September 16, 2011

Therapy Cells Inc

HISTORY TOOLS
CIK: 1429859 Ticker: TCEL

View differences made from one to another to evaluate Therapy Cells Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Therapy Cells Inc.

Continue

Assess how Therapy Cells Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Therapy Cells Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: TCEL
CIK: 1429859
Form Type: 8-K Corporate News
Accession Number: 0001078782-11-002724
Submitted to the SEC: Fri Sep 16 2011 5:22:19 PM EST
Accepted by the SEC: Fri Sep 16 2011
Period: Friday, September 16, 2011
Industry: Wholesale Jewelry Watches Precious Stones And Metals
Events:
  1. New Agreement
  2. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tcel/0001078782-11-002724.htm